This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how CMOs can support value creation in biotechs and how that is influenced buy the current biotech financial climate. Specifically:
- The importance of storytelling and leading thoughtfully
- Effective prioritization and execution towards the company narrative
- Balancing the team to be lean while avoiding the potential pitfalls of running lean
- Balancing the data collected to be interesting to investigators and important for the program to proceed
- Clinical data generation is better than preclinical dreams
- Strategically choosing a first indication and building sufficient scientific bridging to support subsequent indications
To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Moderators
Luke Devey, PhD, MD
CMO
Quell Therapeutics Ltd
Panelists
John Goldberg, MD
CMO, Acting CDO
NanOlogy, Incendia Therapeutics
Scott Harris, MD
Senior Strategic Advisor
Altimmune
Jen Seda, MD
Practice Lead & Senior Vice President, Medical
SSI Strategy
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.